Evelo (EVLO) Posts Positive Data from Phase II Psoriasis Study Posted byZacks Equity Research September 28, 2021 Leave a comment on Evelo (EVLO) Posts Positive Data from Phase II Psoriasis Study Evelo Biosciences (EVLO) reports encouraging data from a phase II study evaluating EDP1815 for the treatment of mild and moderate psoriasis. Shares up…